Tag: regulatory science
IVIVC and Waivers: How In Vitro Methods Are Replacing In Vivo Bioequivalence Testing
IVIVC lets pharmaceutical companies predict how a drug behaves in the body using lab-based dissolution tests, replacing costly and time-consuming human trials. When done right, it saves millions and speeds up generic drug approval.
read morerecent posts
Tramadol can lower the seizure threshold even at normal doses, making it dangerous for people with seizure disorders. Learn why it's contraindicated, who's at risk, and what safer alternatives exist.
Published ON: 24 MarNasal congestion from overused decongestant sprays is common and reversible. Learn how rebound congestion works, why stopping the spray is the only cure, and what actually helps you recover - backed by clinical evidence.
Published ON: 5 MarLearn the critical difference between medication side effects and adverse drug reactions - why confusing them can lead to unnecessary panic, wrong decisions, and even dangerous health outcomes. Clear, science-backed explanation for patients and caregivers.
Published ON: 6 MarFake generic drugs are a growing global threat, infiltrating supply chains through loopholes in regulation, online sales, and grey market distribution. Learn how they’re made, how they get into pharmacies, and what you can do to protect yourself.
Published ON: 19 MarCounterfeit medications are a growing global threat, with millions of fake pills and injections seized each year. Real cases from 2025 reveal how dangerous these fakes are-and what we must do to stop them.
Published ON: 3 Mar